^




Show legend
Group by Gene:
Include preclinical:

nivolumab
pembrolizumab
retifanlimab-dlwr
0
PD1 inhibitor
cemiplimab-rwlc
toripalimab-tpzi
pucotenlimab
PD1 inhibitor
nivolumab + ipilimumab
1
PD1 inhibitor, CTLA4 inhibitor
pembrolizumab + ipilimumab
ipilimumab biosimilar (CS1002) + CS1003
PD1 inhibitor + CTLA4 inhibitor
2
CTLA4 inhibitor
ipilimumab
CTLA4 inhibitor
temozolomide
dacarbazine
3
DNA synthesis inhibitor
cisplatin
cisplatin + dacarbazine
cisplatin + temozolomide
trametinib
selumetinib
CH4987655
binimetinib
4
MEK inhibitor
AS703026
PD-0325901
DS03090629
CI-1040
MEK inhibitor
5
Hedgehog cell-signalling pathway inhibitor
vismodegib
sonidegib
6
ALK inhibitor
crizotinib
ceritinib
avelumab
7
PD-L1 inhibitor
atezolizumab
durvalumab
PD-L1 inhibitor
dabrafenib
GDC 0879
PLX4720
8
BRAF inhibitor
ABM-1310
SB-590885
PF-07284890
BRAF inhibitor
nivolumab / relatlimab
9
PD1 inhibitor, LAG-3 inhibitor
cemiplimab-rwlc + REGN3767
PD1 inhibitor + LAG-3 inhibitor
pazopanib
10
Multi-tyrosine kinase inhibitor
regorafenib
MGCD516
11
BRAF inhibitor, BRAF V600E inhibitor
vemurafenib
FORE-8394
12
GM-CSF agonist
talimogene laherparepvec
ONCOS-102
13
Bcl2 inhibitor, Tubulin inhibitor
albumin-bound paclitaxel
14
PD1 inhibitor, BRAF inhibitor
pembrolizumab + dabrafenib
PD1 inhibitor + BRAF inhibitor
15
Topoisomerase II inhibitor, DNA inhibitor, DNA synthesis inhibitor
cisplatin + etoposide oral
16
Tubulin polymerization promoter
carboplatin
17
GM-CSF agonist, CTLA4 inhibitor
ipilimumab + talimogene laherparepvec
18
Topoisomerase I inhibitor
topotecan
trametinib + dabrafenib
19
MEK inhibitor, BRAF inhibitor
dabrafenib + DS03090629
PD-0325901 + BGB-3245
BRAF inhibitor + MEK inhibitor
20
VEGFR-2 inhibitor, PD1 inhibitor
camrelizumab + rivoceranib
DAY101
21
pan-RAF inhibitor
KIN-2787
RG6185
LY3009120
BVD-523
22
ERK2 inhibitor, ERK1 inhibitor
JSI-1187
LY3214996
ASN007
23
HDAC inhibitor
vorinostat
24
pan-RAF inhibitor, MEK1 inhibitor
cobimetinib + RG6185
ribociclib
25
CDK4 inhibitor, CDK6 inhibitor
palbociclib
dalpiciclib
abemaciclib
26
Bcr-abl tyrosine kinase inhibitor
nilotinib
27
Immunostimulant, PD1 inhibitor
pembrolizumab + EVX-01
28
IFNα 2b stimulant
interferon α-2b
29
VEGFR-2 inhibitor, DNA synthesis inhibitor
temozolomide + rivoceranib
30
TLR9 agonist
AST-008
31
PD1 inhibitor, IDO1 inhibitor
pembrolizumab + INCB024360
nivolumab + BMS-986205
32
Immunostimulant, Dendritic cell activator
PVS-RIPO
33
IL-2R agonist
ALKS 4230
34
Immunostimulant
ITI-3000
35
TrkB receptor inhibitor, TrkC kinase inhibitor, TrkA receptor inhibitor
larotrectinib
36
PD1 inhibitor, IDO inhibitor
pembrolizumab + NLG8189
nivolumab + NLG8189
37
MEK1 inhibitor
cobimetinib
cobimetinib
38
VEGF-A inhibitor
bevacizumab
39
STAB1 inhibitor
bexmarilimab
40
PD1 inhibitor, BRAF inhibitor, BRAF V600E inhibitor
vemurafenib + toripalimab-tpzi
pembrolizumab + vemurafenib
41
HER2 inhibitor, HER2 dimerization inhibitor
trastuzumab + pertuzumab
42
PD1 inhibitor, PARP inhibitor
nivolumab + olaparib
43
KRAS G12C inhibitor
sotorasib
44
ATR inhibitor
AZD6738
45
PI3Kβ inhibitor, PD1 inhibitor
pembrolizumab + GSK2636771
46
MEK inhibitor, MDM2 inhibitor
trametinib + KRT-232
47
PI3K inhibitor
GDC-0941
AN2025
48
MDM2 inhibitor
KRT-232
RAIN-32
49
MAGE-A3 modulator
MAGE-A3 vaccine
50
TIGIT inhibitor
EOS-448
51
ALK inhibitor, BRAF inhibitor, BRAF V600E inhibitor
crizotinib + vemurafenib
52
VEGFR inhibitor, PD1 inhibitor
toripalimab-tpzi + axitinib
53
gp100 inhibitor
tebentafusp-tebn
54
PRMT5 inhibitor
MRTX1719
55
DNA synthesis inhibitor, PD1 inhibitor
nivolumab + temozolomide
56
GSK3β inhibitor
9-ING-41
57
PD-L1 inhibitor, BRAF inhibitor, MEK1 inhibitor, BRAF V600E inhibitor
atezolizumab + vemurafenib + cobimetinib
58
pan-RAF inhibitor, Multi-tyrosine kinase inhibitor
sorafenib
59
TrkB receptor inhibitor, TrkC kinase inhibitor, ROS1 inhibitor, TrkA receptor inhibitor, ALK inhibitor, JAK2 inhibitor, TNK2 inhibitor
entrectinib
60
PDGFR inhibitor, Bcr-abl tyrosine kinase inhibitor, c-KIT inhibitor
imatinib
trametinib + dabrafenib + PDR001
61
PD1 inhibitor, MEK inhibitor, BRAF inhibitor
pembrolizumab + trametinib + dabrafenib
nivolumab + trametinib + dabrafenib
PD1 inhibitor + BRAF inhibitor + MEK inhibitor
62
PD1 inhibitor, MEK inhibitor
pembrolizumab + trametinib
PD1 inhibitor + MEK inhibitor
63
CD122 agonist, IL-2 stimulant
aldesleukin
64
FGFR inhibitor, VEGFR inhibitor, RET inhibitor, PD1 inhibitor, c-KIT inhibitor, PDGFR α antagonist
pembrolizumab + lenvatinib
65
Tubulin polymerization promoter, Bcl2 inhibitor
paclitaxel
66
TLR7 agonist, TLR8 agonist
imiquimod
67
Topoisomerase II inhibitor, Tubulin polymerization promoter, DNA inhibitor
carboplatin + etoposide oral
68
Tubulin polymerization promoter, DNA synthesis inhibitor, Bcl2 inhibitor, Tubulin inhibitor
paclitaxel + albumin-bound paclitaxel + dacarbazine
69
PD1 inhibitor, GM-CSF agonist
PD1 inhibitor + talimogene laherparepvec
70
MEK inhibitor, MEK2 inhibitor, MEK1 inhibitor
HL-085
71
BRAF inhibitor, MEK1 inhibitor, BRAF V600E inhibitor
vemurafenib + cobimetinib
72
cRAF inhibitor, BRAF inhibitor
encorafenib
RAF709
73
cRAF inhibitor, MEK inhibitor, BRAF inhibitor
binimetinib + encorafenib
trametinib + encorafenib
74
PDGFR β inhibitor, PDGFR α inhibitor, FLT3 inhibitor
ARO-002
75
TLR9 agonist, PD1 inhibitor, Immunomodulator
nivolumab + CMP-001
pembrolizumab + CMP-001
76
Bcr-abl tyrosine kinase inhibitor, Src kinase inhibitor, c-KIT inhibitor, PDGFR β antagonist, EphA2 receptor antagonist
dasatinib
77
CD40 agonist, TLR4 antagonist, CD70 inhibitor
ex-vivo autologous dendritic cells vaccine
78
PD-L1 inhibitor, MEK1 inhibitor
atezolizumab + cobimetinib
79
pan-RAF inhibitor, EGFR inhibitor
BGB-283
cetuximab + BGB659
80
pan-RAF inhibitor, cRAF inhibitor, MEK inhibitor, BRAF inhibitor
trametinib + ERAS-254
81
VEGFR inhibitor, PDGFR inhibitor, c-KIT inhibitor
sunitinib
82
Immunostimulant, MAGE-A3 inhibitor, Protein tyrosine phosphatase inhibitor, Tyrosinase inhibitor, NY ESO 1 inhibitor
BNT111
83
PD-L1 inhibitor, PD1 inhibitor, IDO inhibitor
nivolumab + IO102-IO103
84
MEK inhibitor, BRAF inhibitor, CSF-1 inhibitor
trametinib + dabrafenib + MCS110
85
PD1 inhibitor, BRAF inhibitor, MEK1 inhibitor, BRAF V600E inhibitor
pembrolizumab + vemurafenib + cobimetinib
86
CDK4 inhibitor, BRAF inhibitor, CDK6 inhibitor, BRAF V600E inhibitor
palbociclib + vemurafenib
87
Alkylating agent, DNA synthesis inhibitor
fotemustine
88
PDGFR α inhibitor, c-KIT inhibitor, FLT3 inhibitor
ripretinib
89
MAP4K2 inhibitor, TAK1 inhibitor
TL-1-85
90
DLL3-targeted antibody-drug conjugate, DNA replication inhibitor
rovalpituzumab tesirine
REC-4881
91
MEK2 inhibitor, MEK1 inhibitor
FCN-159
U0126
92
pan-RAF inhibitor, cRAF inhibitor, PD1 inhibitor, BRAF inhibitor
PDR001 + ERAS-254
93
HDAC inhibitor, HDAC1 inhibitor, PD1 inhibitor, LSD1 inhibitor, HDAC2 inhibitor, HDAC3 inhibitor
nivolumab + 4SC-202
94
AMPK activator, MEK inhibitor, mTOR inhibitor, BRAF inhibitor
trametinib + dabrafenib + phenformin
95
MEK inhibitor, PI3K inhibitor, mTOR inhibitor
selumetinib + RTB101
trametinib + GSK2126458
96
MEK inhibitor, BRAF inhibitor, Bcl2 inhibitor, Bcl-xL inhibitor, Bcl-w inhibitor
trametinib + dabrafenib + ABT 263
97
PD-L1 inhibitor, gp100 inhibitor
durvalumab + tebentafusp-tebn
98
BRAF inhibitor, BRAF V600E inhibitor, Cytochrome P450 inhibitor
FORE-8394 + cobicistat
99
PD-L1 inhibitor, MEK inhibitor
trametinib + durvalumab
100
PD-L1 inhibitor, MEK inhibitor, BRAF inhibitor
trametinib + dabrafenib + durvalumab
101
BRAF inhibitor, MDM2 inhibitor
dabrafenib + KRT-232
102
HER2-targeted antibody-drug conjugate, Microtubule inhibitor
ado-trastuzumab emtansine
103
PDGFR antagonist, mutant c-KIT inhibitor, CSF-1R inhibitor
avapritinib
trametinib + palbociclib
104
CDK4 inhibitor, MEK inhibitor, CDK6 inhibitor
binimetinib + ribociclib
palbociclib + binimetinib
MEK inhibitor + CDK4 inhibitor + CDK6 inhibitor
105
cRAF inhibitor, PD1 inhibitor, MEK inhibitor, BRAF inhibitor, CTLA4 inhibitor
nivolumab + ipilimumab + binimetinib + encorafenib
106
HER2 inhibitor, EGFR inhibitor
lapatinib
107
Microtubule stabilizer, Tubulin polymerization promoter, Sortilin inhibitor
TH 1902
108
cRAF inhibitor, PD1 inhibitor, MEK inhibitor, BRAF inhibitor
pembrolizumab + binimetinib + encorafenib
109
T lymphocyte replacement, Immunostimulant
lifileucel
110
MEK inhibitor, BRAF inhibitor, MDM2 inhibitor
trametinib + dabrafenib + KRT-232
111
PD-L1 inhibitor, gp100 inhibitor, CTLA4 inhibitor
durvalumab + tremelimumab + tebentafusp-tebn
112
HSP90 inhibitor, BRAF inhibitor, BRAF V600E inhibitor
vemurafenib + XL888
113
FGFR inhibitor, VEGFR inhibitor, RET inhibitor, BRAF inhibitor, c-KIT inhibitor, PDGFR α antagonist
dabrafenib + lenvatinib
114
Hedgehog cell-signalling pathway inhibitor, PD1 inhibitor
nivolumab + vismodegib
115
CD137 agonist, HER2 inhibitor
PRS-343
116
PDGFR inhibitor, Bcr-abl tyrosine kinase inhibitor, PD1 inhibitor, c-KIT inhibitor
imatinib + toripalimab-tpzi
117
pan-RAF inhibitor, VEGF-A inhibitor, mTOR inhibitor, Multi-tyrosine kinase inhibitor
bevacizumab + sorafenib + temsirolimus
118
PD-L1 inhibitor, Immunostimulant
atezolizumab + RG6180
119
pan-RAF inhibitor, MEK inhibitor, EGFR inhibitor
PD-0325901 + BGB-283
120
mTOR inhibitor
temsirolimus
121
JAK1 inhibitor, JAK2 inhibitor
ruxolitinib
122
JAK2 inhibitor, FLT3 inhibitor
fedratinib
123
DNA synthesis inhibitor, PD1 inhibitor, MEK inhibitor, CTLA4 inhibitor
pembrolizumab + nivolumab + trametinib + ipilimumab + dacarbazine
124
EZH2 inhibitor
GSK2816126
JQEZ5
125
AKT inhibitor
capivasertib
MK-2206
126
pan-RAF inhibitor, SRC-family kinase (SFK) inhibitor
CCT241161 + CCT196969
CCT241161
127
BRAF inhibitor, AKT inhibitor
dabrafenib + LAE003
128
cRAF inhibitor, BRAF inhibitor, BRAF V600E inhibitor
encorafenib + FORE-8394
vemurafenib + dabrafenib + encorafenib
129
PKC inhibitor
IDE196
130
PI3Kγ inhibitor, PI3Kδ inhibitor
duvelisib
131
CDC42 inhibitor
ARN22089
132
STING agonist
CS-1018
133
ATR inhibitor, PARP inhibitor
olaparib + AZD6738
134
Aurora kinase B inhibitor, BRAF inhibitor
HI-511
135
PI3Kβ inhibitor, OX40 ligand inhibitor
GSK2636771 + ENUM004
trametinib + LY3009120
136
pan-RAF inhibitor, MEK inhibitor
trametinib + AZ 628
binimetinib + KIN-2787
MEK inhibitor + pan-RAF inhibitor
137
CDK4 inhibitor, PI3K inhibitor, mTOR inhibitor, CDK6 inhibitor, WEE1 inhibitor
palbociclib + AZD1775 + PI-103
138
WEE1 inhibitor
AZD1775
139
HSP90 inhibitor
XL888
140
ERK2 inhibitor
VTX-11e
141
MEK inhibitor, AKT inhibitor
selumetinib + MK-2206
SCH772984
142
ERK inhibitor
KO-947
DEL-22379
143
PFKFB3 inhibitor
3PO
144
CD56-targeted antibody-drug conjugate, Microtubule inhibitor
McSAF 03
145
MAP3K1 inhibitor, ACVR1 inhibitor, MEK2 inhibitor, MEK1 inhibitor, FLT3 inhibitor
E6201
146
pan-RAF inhibitor, Apoptosis inducer, PP2A activator, Multi-tyrosine kinase inhibitor
sorafenib + nanoliposomal ceramide
147
SRC-family kinase (SFK) inhibitor
SAB298
148
MERTK inhibitor
RGX-019
149
KRAS G12C inhibitor, MEK2 inhibitor, MEK1 inhibitor
sotorasib + IMM-1-104
150
PI3K inhibitor, FAK inhibitor, AKT inhibitor
LY294002
151
CAR-T immunotherapy
AMT-253
152
PARP inhibitor, ATM kinase inhibitor
talazoparib + KU-55933
153
EZH1 inhibitor, EZH2 inhibitor
UNC1999
154
EZH2 inhibitor, BRAF inhibitor
dabrafenib + JQEZ5
155
MERTK inhibitor, MEK1 inhibitor, FLT3 inhibitor
cobimetinib + UNC2025
156
BRAF inhibitor, BRAF V600E inhibitor, AKT inhibitor
vemurafenib + MK-2206
157
eIF4G1 inhibitor, NF-κB inhibitor, mTORC1 inhibitor, AKT inhibitor
SBI-756
SBI-726
158
HER3-targeted antibody-drug conjugate, Topoisomerase I inhibitor
U3-1402
159
BET inhibitor
JQ-1
160
PI3K inhibitor, mTOR inhibitor
RTB101
161
MERTK inhibitor, FLT3 inhibitor
UNC2025
162
c-KIT inhibitor
MP470
163
MEK inhibitor, TAK1 inhibitor
trametinib + EDHS-206
164
pan-RAF inhibitor, PD-L1 inhibitor
atezolizumab + RG6185
165
MCL1 inhibitor, cRAF inhibitor, BRAF inhibitor
encorafenib + S63845
166
DNA methylation inhibitor
TdCyd
167
mTOR inhibitor, PDK1 inhibitor
everolimus + dichloroacetate topical
168
DDX5 degrader
FL118
169
Alkylating agent
lomustine
chlorambucil
170
AXL inhibitor
BGB324
171
AXL inhibitor, BRAF inhibitor, BRAF V600E inhibitor
vemurafenib + BGB324
172
PIK3CA inhibitor, MEK inhibitor
trametinib + alpelisib
173
PIK3CA inhibitor, BRAF inhibitor
dabrafenib + alpelisib
174
HDAC inhibitor, cRAF inhibitor, BRAF inhibitor
encorafenib + OKI-179
175
HDAC inhibitor, MEK inhibitor
binimetinib + OKI-179
176
T-cell stimulant, CD27 agonist, PD1 inhibitor
nivolumab + CDX 1127
177
IDH1 inhibitor
ivosidenib
178
RET inhibitor, FLT3 inhibitor
AST-487
179
pan-RAF inhibitor, DDR inhibitor
PHI-501
180
PI3K inhibitor, mTOR inhibitor, AKT inhibitor
GDC-0084
181
pan-RAF inhibitor, MEK inhibitor, Multi-tyrosine kinase inhibitor
trametinib + sorafenib
182
Microtubule inhibitor, CD228-targeted antibody-drug conjugate
SGN-CD228A
183
Topoisomerase II inhibitor
doxorubicin hydrochloride
184
IDH1 inhibitor, BRAF inhibitor
dabrafenib + ivosidenib
185
PI3K inhibitor, PI3Kγ inhibitor, BRAF V600E inhibitor, PI3Kδ inhibitor
CB-006-3
186
CDK inhibitor
MK-7965
187
HLA-DR-targeted antibody-drug conjugate, Topoisomerase I inhibitor
IMMU-140
188
MEK inhibitor, TYRP1 inhibitor
MEK inhibitor + TA99
189
Immunotherapy
Immunotherapy
190
STAT3 inhibitor, PD1 inhibitor
PD1 inhibitor + STAT3 inhibitor
EP
CAV
191
Chemotherapy
TC
CVD
CaT
192
T-lymphocyte cell therapy
T-lymphocyte cell therapy
193
PD-L1 inhibitor, PD1 inhibitor
PD1 inhibitor + PD-L1 inhibitor
194
PLK1 inhibitor, BRAF inhibitor
BRAF inhibitor + PLK1 inhibitor
195
PD-L1 inhibitor, CTLA4 inhibitor
PD-L1 inhibitor + CTLA4 inhibitor
No biomarker
BRAF V600
BRAF V600E
BRAF mutation
BRAF fusion
BRAF wild-type
BRAF V600K
BRAF V600DK601del
BRAF K601E
BRAF V600 wild-type
BRAF V600E + BRAF V600K
BRAF V600D
BRAF V600M
BRAF V600R
BRAF L597K
BRAF L597R
BRAF L597S
BRAF L597Q
BRAF positive
BRAF D594G
BRAF G469S
BRAF V600G
BRAF G469E
BRAF T1799A
BRAF D549G
BRAF L505H
BRAF rearrangement
BRAF G464E
BRAF amplification
NRAS mutation
NRAS Q61L
NRAS wild-type
NRAS Q60H
NRAS G12S
NRAS Q61H
NRAS G12D
NRAS Q61R
NRAS G13R
NRAS Q61K
NRAS overexpression
NRAS amplification
NRAS Q61
NRAS A146T
NRAS G13D
TMB-H
TMB-L
KIT mutation
KIT amplification
KIT exon 17 mutation
KIT exon 11 mutation
KIT exon 13 mutation
KIT L576
KIT K642E
KIT fusion
KIT translocation
KIT V559A + KIT N822I
KIT wild-type
KIT A829P
KIT D820Y
KIT V559D
KIT S628N
KIT T670I
KIT L576P
KIT overexpression
ROS1 fusion
ALK fusion
PD-L1 expression
PD-L1 overexpression
PD-L1 underexpression
PD-L1 negative
PD-L1 elevation
ALK mutation
TMB-H + LDH elevation
TMB-L + LDH elevation
CCND1 amplification
KRAS amplification
MAP2K1 P124S
MAP2K1 mutation
KRAS mutation
MAP2K1 C125S
MAP2K1 F53Y
KRAS G12C
MAP2K1 G276W
CCND1 underexpression
MAP2K1 S218D + MAP2K1 S222D
MAP2K1 P124Q
MAP2K1 P124L
MAP2K1 G128V
MAP2K1 K57N
MAP2K1 V154I
MAP2K1 Q56P
MAP2K1 E203K
MAP2K1 C121S
MAP2K1 K59del
MAP2K1 K57E
MAP2K1 V60E
MAP2K1 P124
KRAS G13D overexpression
KRAS overexpression
MAP2K1 F129L
LAG3 expression
TMB-H + PD-L1 negative
BRAF V600 + LDH elevation
PDGFRA P577S
PTEN mutation
PDGFRA G853D
LAG3 overexpression
PDGFRA R841K
PDGFRA H845Y
PTEN R233X
PD-L1 expression + TMB-H
PTEN K128T
PTEN H93D
BRAF V600K + LDH elevation
PTEN deletion
PTEN P204S
PDGFRA V658A
LDH elevation + BRAF mutation
TERT amplification
BRAF V600 + LDH elevation + PD-L1 negative
LDH elevation
MUC16 mutation
LDHB-L + PD-L1 expression
KIAA1549-BRAF fusion
LDHA-L + PD-L1 expression
RAF1 amplification
HER-2 amplification
IDO1 positive
CD8 expression
HER-2 positive
IDO1 expression
CD8 overexpression
CD8 positive
IDO1 overexpression
RAF1 R391W
TP53 wild-type
GNAQ mutation
IFNG-L
BRAF mutation + MEK1 P124L
PTCH1 S616G
PD-1 expression
BRAF V600E + CDKN2A deletion + RB1 expression
PTCH1 mutation
NTRK1 mutation
PD-1-L
CTAG1B antibody elevation
GNA11 Q209L
CDKN2A deletion
BRAF V600E + MAP2K1 I111S
CTLA4 overexpression
NTRK1 fusion
IFNG overexpression
BRAF V600K + CDKN2A deletion + RB1 expression
KDR elevation
CDKN2A exon 2 mutation
GNA11 mutation
CTAG1B overexpression
CTLA4 expression
KDR Q472H
GNAQ Q209P
TP53 mutation
TP53 deletion
CDKN2A promoter methylation
CDKN2A mutation
PD-1 overexpression
BRAF mutation + MAP2K1 mutation
CDKN2A deletion
JAK2 underexpression
IRF1 expression
TIGIT overexpression
TNFRSF9 overexpression
ADORA2A overexpression
ADAR overexpression
CDK4 amplification
CARD11 mutation
NLRC5 overexpression
GAS1 underexpression
PCSK9 underexpression
ECM2 mutation
PALB2 mutation
PTPN11 mutation + TMB-H
ACSL4 overexpression
MAP2K2 mutation
RECQL5 mutation + TMB-H
STAT2 expression
CSF2 expression
CD9 expression
KMT2C mutation
TPSAB1 expression
MDC1 mutation
FSIP2 mutation
ARID1A mutation
MSI-H/dMMR
HRAS mutation
NLRP3 mutation
GDF15-L
PD-L1 elevation + CXCL10 elevation + TNFA elevation
miR-100-5p overexpression
IFIT3 overexpression
IFIT1 overexpression
miR-125b-5p overexpression
PTPRT mutation
CRKL mutation
LYN mutation
SYK mutation
RET mutation
PIK3CG mutation
TERT promoter mutation + BRAF V600
COL3A1 mutation
GRIN2A mutation
TNFA-L
EEF2K overexpression
HLA-A2 positive + PMEL overexpression
PAPPA2 mutation
CD8 elevation + BRAF V600
FAT1 mutation
CD8 underexpression + HAVCR2 overexpression
PAPPA2 mutation + TMB-H
NRAS wild-type + NOTCH4 mutation
IGKC overexpression
HHLA2 overexpression
IL6 elevation + HGF elevation + CCL8 elevation
PMS2 mutation
CD69 overexpression
SBK1 overexpression
SERPINB3 mutation
ITGAE overexpression
PPL underexpression + SOX10 underexpression
PPL underexpression
FGFR2 mutation
FGFR1 mutation
FGFR4 mutation
FGFR3 mutation
RELN mutation
High IFNG gene signature + TMB-H
MAGEA4 overexpression
MAGEA3 overexpression
SP140 overexpression
TTN mutation
BTN2A1-H
SCUBE1 mutation
ALPK2 mutation
VPS13D mutation
IL23 elevation
CXCL6-L
IL10-L
CD200 underexpression
VEGFA-L
CCL2 elevation
CCL11 elevation
RPTOR mutation
NCR3LG1 underexpression
NCR3LG1 underexpression + TMB-L
ICOS overexpression
HLA-A*02:01
SLC35A2 overexpression
NEAT1 overexpression
SETBP1 mutation
HYDIN mutation
S100A9 elevation
S100A8 elevation
AIM2 overexpression
GZMK overexpression
GZMH overexpression
PD-L2 overexpression
CD52 overexpression
DLL3 expression
NCAM1 expression
NKX2-1 expression
PTCH1 1504-1G>T + TMB-H
CDKN2A Negative + NRAS Mutation
PPFIBP2-BRAF fusion
ZKSCAN1-BRAF fusion
CXCL10 elevation
IL32 overexpression
PIK3CA H1047R
TCF7 overexpression + CD8 overexpression
GOLGA4-RAF1 fusion
BRAF V600E + PD-L1 expression
HRD
TRIM33-BRAF fusion
CDKN2A deletion + CDKN2B deletion + MTAP deletion + TERT mutation
SERPINB4 mutation
POLE mutation
MAP2K1 mutation + TMB-H
MAP2K2 mutation + TMB-H
MAP3K14 mutation + TMB-H
HSPB1 expression
CBL mutation
miR-524-5p overexpression
CD27 overexpression
LDHB overexpression
CD28 overexpression
CD7 overexpression
CD2 overexpression
KIR3DL2 overexpression
ENTPD1 overexpression
PIK3R1 overexpression
PRF1 overexpression
ARID2 mutation
MYC amplification
RPS6KB1 amplification
MLANA antibody elevation
DCT antibody elevation
TYRP1 antibody elevation
IFNAR1 expression
TIAM1 overexpression
CD22 overexpression
CCL19 overexpression
LY9 overexpression
THY1 overexpression
CUL1 underexpression
JAML overexpression
CD3D overexpression
AAMP underexpression
IL12RB1 overexpression
C1S overexpression
C7 overexpression
NFKBIE mutation + TMB-H
TET1 mutation
CMTM6 overexpression + PD-L1 overexpression
SORT1 expression
BAP1 mutation
ERBB4 mutation
NTRK2 fusion
NTRK3 fusion
JAK2 F547
PIK3CG expression
BRAF mutation + TERT −124C>T
BRAF mutation + TERT overexpression
TERT mutation + BRAF V600E
BRAF mutation + TERT −138CC>TT
BRAF mutation + TERT −139CC>TT
PIK3CA E545G
MAP2K2 V35M
MAP2K2 N126D
TYRP1 overexpression
PIK3CA D350G
MEK2 F57C
MAP2K2 C125S
PIK3CA mutation
PIK3CA E545K
MAP2K2 L46F
CARD11 amplification
MAP2K2 Q60P
GDF15 elevation
ICOS Methylation
PIK3CG overexpression
BRAF mutation + TERT −146C>T
IFNG gene signature overexpression
High IFNG gene signature
IFNG gene signature
84-gene expression signature
DDR
Choline elevation
TASL expression
IDH1 overexpression
HLA-DRA expression
NF1 deletion
MYD88 overexpression
TLR8 overexpression
NF1 mutation
TLR5 overexpression
MERTK expression
IL6 elevation
HGF elevation
RAC1 P29S
STAG2 underexpression
STAG3 underexpression
MAP3K8 overexpression
IL1RN overexpression
FCGR2A overexpression
MTAP mutation + CDKN2A mutation
SEMA6A overexpression + BRAF mutation
AEBP1 overexpression
PDGFRB overexpression
IL18 overexpression
IFI16 overexpression
EZH2 Y641F
EZH2 positive
MTOR P2213S
MTOR H1968Y
NARS2 mutation
RPS6KA3 overexpression
CD73 overexpression
SESN2 overexpression
STING expression
MDM2 amplification
NF2 deletion
MDM4 amplification
mTOR amplification
BIRC2 amplification
SF3B1 mutation
SLC31A2 expression
COL4A5 expression
AKT1 Q79K
ERBB3 expression
RB1 deletion
EML4-ALK fusion
EGFR amplification
MELTF overexpression
MTOR S2215Y
MET overexpression
SMO mutation
CD20 positive
EZR overexpression + BRAF V600E
AXIN1 deletion
NRAS mutation + BRAF mutation
SOX10 underexpression
CCNE1 amplification
NF1 R2450X
ARAF mutation + NRAS mutation
TET2 deletion + DNMT3A mutation
MAP1LC3B overexpression
B2M mutation
JAK1 Q503*
PHLPP1 mutation
BRAF mutation + NF1 mutation
AKT1 E17K
BRAF mutation + EGFR mutation
HOXD8 mutation
AKT3 E17K
MAPK1 overexpression
JAK1 P429S
TINCR overexpression
miR-19b1 underexpression
GLI1 overexpression
AGK-BRAF fusion
ROR2 overexpression
SMO D473G
SMO S533N
SKAP2-BRAF fusion
SMO D473H
SMO Q477E
SMO W535L
ATXN1L underexpression
EZH2 Y646
AKT1 E17K + BRAF V600
IGFBP2 overexpression + PD-L1 overexpression
USP6 mutation
NR2F1 overexpression
PRKCH-SPTB fusion
PRKCH fusion
PIK3CD overexpression
TNFAIP3 overexpression + BRAF mutation
PIK3CD expression
STING mutation
C4G elevation + PRO-C3 underexpression
AXL overexpression
HIF1A-PRKCH fusion
PRKCH-VWA2 fusion
TRIB3 overexpression
NUSAP1 overexpression
EGFR L858R + EGFR T790M
AURKB overexpression
miR-211 expression
BRAF V600E + PTEN deletion
PD-1 positive + TIGIT positive + CD8 positive
TARDBP-BRAF fusion
FKBP15-BRAF fusion
CUL1-BRAF fusion
MCAM expression
ATM W2845
PAK4 overexpression
KRAS G13D + BRAF mutation
NRAS G12C + BRAF mutation
AXL expression
KEAP1 negative
PD-L1 overexpression + SOX2 overexpression
MITF amplification
CXCR6 expression + HAVCR2 expression
NRAS Q61K + BRAF V600E
NRAS mutation + BRAF wild-type
EGFR mutation
TCF7L2 deletion
NFKB1 overexpression
TNFRSF1B overexpression
HSPA1A elevation
CCL8 elevation